127 related articles for article (PubMed ID: 6176311)
1. Bleomycin and mitomycin-C (BLM-M) in recurrent squamous uterine cervical carcinoma.
Boice CR; Freedman RS; Herson J; Wharton JT; Rutledge FN
Cancer; 1982 Jun; 49(11):2242-5. PubMed ID: 6176311
[TBL] [Abstract][Full Text] [Related]
2. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
[TBL] [Abstract][Full Text] [Related]
3. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
5. [Bleomycin combined with mitomycin C in recurrent cervix cancer].
Tropé C; Simonsen E; Johnsson JE; Sigurdsson K
Lakartidningen; 1982 Apr; 79(17):1689-91. PubMed ID: 6178913
[No Abstract] [Full Text] [Related]
6. Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study.
Leichman LP; Baker LH; Stanhope CR; Samson MK; Fraile RJ; Vaitkevicius VK; Hilgers R
Cancer Treat Rep; 1980; 64(10-11):1139-40. PubMed ID: 6161699
[TBL] [Abstract][Full Text] [Related]
7. Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix.
Vermorken JB; vd Burg ME; Subandono AJ; Mangioni C; De Oliveira CF; Zola P; van Oosterom AT; Pecorelli S; van Lindert AC
Prog Clin Biol Res; 1985; 201():225-37. PubMed ID: 2419917
[No Abstract] [Full Text] [Related]
8. Chemotherapy of squamous cell carcinoma of the cervix.
Llorens AS
Obstet Gynecol; 1980 Mar; 55(3):373-5. PubMed ID: 6153782
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of mitomycin-C, vincristine, and bleomycin in advanced squamous cell carcinoma of the uterine cervix.
Baker LH; Opipari MI; Izbicki RM
Cancer; 1976 Dec; 38(6):2222-4. PubMed ID: 63314
[TBL] [Abstract][Full Text] [Related]
10. Recent results of using a sequential combination of bleomycin and mitomycin C in the treatment of metastatic cervical cancer.
Miyamoto T
Recent Results Cancer Res; 1980; 70():211-7. PubMed ID: 6153471
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in recurrent or metastatic cervical cancer.
Deka AC; Deka BC; Patil RB; Joshi SG
Indian J Cancer; 1979; 16(3-4):32-7. PubMed ID: 94302
[No Abstract] [Full Text] [Related]
13. Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix.
Alberts DS; Martimbeau PW; Surwit EA; Oishi N
Cancer Clin Trials; 1981; 4(3):313-6. PubMed ID: 6169465
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bleomycin, adriamycin and mitomycin-C in the treatment of recurrent cervical cancer.
Meanwell CA; Luesley DM; Blackledge G; Mould JJ; Chan KK; Perren TJ; Lawton FG
Br J Obstet Gynaecol; 1985 Jul; 92(7):756-61. PubMed ID: 2410013
[TBL] [Abstract][Full Text] [Related]
15. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Lele SB; Piver MS
Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
van Luijk IF; Coens C; van der Burg ME; Kobierska A; Namer M; Lhomme C; Zola P; Zanetta G; Vermorken JB;
Ann Oncol; 2007 Feb; 18(2):275-81. PubMed ID: 17060485
[TBL] [Abstract][Full Text] [Related]
17. A sequential combination of bleomycin and mitomycin C in the treatment of advanced squamous cancers.
Miyamoto T
Recent Results Cancer Res; 1978; 63():179-90. PubMed ID: 81501
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin-mitomycin C in advanced carcinoma of the cervix. A third look.
Tropé C; Johnsson JE; Simonsen E; Sigurdsson K; Stendahl U; Mattsson W; Gullberg B
Cancer; 1983 Feb; 51(4):591-3. PubMed ID: 6185206
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer.
Baker LH; Opipari MI; Wilson H; Bottomley R; Coltman CA
Obstet Gynecol; 1978 Aug; 52(2):146-50. PubMed ID: 79991
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a sequential combination of bleomycin and mitomycin-C on an advanced cervical cancer.
Miyamoto T; Takabe Y; Watanabe M; Terasima T
Cancer; 1978 Feb; 41(2):403-14. PubMed ID: 75759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
